Stock 002755 BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Beijing Aosaikang Pharmaceutical Co., Ltd.

Equities

002755

CNE100001X92

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
9.8 CNY +0.41% Intraday chart for Beijing Aosaikang Pharmaceutical Co., Ltd. +14.75% -9.43%
Apr. 28 Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 05 Beijing Aosaikang Pharma's Unit Gets Nod to Market Delafloxacin for Injection MT

Business Summary

BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD., formerly Beijing New Oriental Star Petrochemical Engineering Co., Ltd., is a China-based company mainly engaged in pharmaceutical manufacturing business. The Company produces proton pump inhibitor injections through its subsidiary Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Number of employees: 1,215

Sales per Business

CNY in Million2021Weight2022Weight Delta
Digestive
45.7 %
1,906 61.4 % 856 45.7 % -55.09%
Anti-Tumor
34.8 %
800 25.7 % 651 34.8 % -18.54%
Other
18.8 %
336 10.8 % 352 18.8 % +4.72%
Other Business
0.7 %
65 2.1 % 14 0.7 % -79.13%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
100.0 %
3,107 100.0 % 1,873 100.0 % -39.72%

Managers

Managers TitleAgeSince
Jing Fei Ma CEO
 Chief Executive Officer 36 19-09-29
Tao Han DFI
 Director of Finance/CFO 42 19-02-17
You Yin Xu BRD
 Director/Board Member 56 19-02-17
Cai Xia Ren IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Jian Wen Liu BRD
 Director/Board Member 65 19-02-17
Qing Chen CHM
 Chairman 65 19-02-17
You Yin Xu BRD
 Director/Board Member 56 19-02-17
Jing Chen CHM
 Chairman 56 19-02-17
Xiao Wen Wang BRD
 Director/Board Member 56 22-02-17
Xiao Ming Wu BRD
 Director/Board Member 69 19-02-17
Di Li BRD
 Director/Board Member 68 18-02-18
Xiang Feng Chen BRD
 Director/Board Member 54 19-02-17
Hong Fang Xue BRD
 Director/Board Member 47 22-02-17
Yan Rong Zhao BRD
 Director/Board Member 46 22-02-17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 928,160,351 169,070,926 ( 18.22 %) 0 18.22 %

Shareholders

NameEquities%Valuation
Qing Chen
34.20 %
317,470,588 34.20 % 464 M ¥
Jun Zhao
14.90 %
138,337,647 14.90 % 202 M ¥
Xiao Zhao
14.45 %
134,113,436 14.45 % 196 M ¥
Weirui Development Co. Ltd.
12.22 %
113,382,352 12.22 % 166 M ¥
Nanjing Haiji Investment Management Co. Ltd.
4.072 %
37,794,117 4.072 % 55 M ¥
Hui Li Chen
1.412 %
13,103,380 1.412 % 19 M ¥
Wei Meng Qu
0.2911 %
2,702,300 0.2911 % 4 M ¥
Xiao Qi Zhao
0.2640 %
2,450,000 0.2640 % 4 M ¥
Bao Cheng Wang
0.1765 %
1,638,450 0.1765 % 2 M ¥
Everbright PGIM Fund Management Co. Ltd.
0.1002 %
930,300 0.1002 % 1 M ¥

Company contact information

Beijing Aosaikang Pharmaceutical Co., Ltd.

699 Kejian Road Jiangning Science Park

211112, Nanjing

+

http://www.ask-pharm.com/
address Beijing Aosaikang Pharmaceutical Co., Ltd.(002755)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD. Stock Beijing Aosaikang Pharmaceutical Co., Ltd.
-9.43% 1.26B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.03% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.94% 231B
NOVARTIS AG Stock Novartis AG
+5.01% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.41% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002755 Stock
  4. Company Beijing Aosaikang Pharmaceutical Co., Ltd.